Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03905486Completed
Randomised, open-label trial of milnacipran in fibromyalgia (FM). Primary endpoint: Fibromyalgia Impact Questionnaire at 3 months. Started Apr 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03905486.